Unexpected effect of probiotics by Lactococcus lactis subsp. lactis against colitis induced by dextran sulfate sodium in mice
Ulcerative colitis (UC) is a representative intestinal chronic inflammatory disease whose incidence is rapidly increasing worldwide. It was previously shown that some specific probiotics help to guard against UC. In this study, we analyzed the effect of Lactococcus lactis subsp. lactis JCM5805 (L. l...
Saved in:
| Published in | Journal of Infection and Chemotherapy Vol. 26; no. 6; pp. 549 - 553 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Ltd
01.06.2020
Elsevier BV |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Ulcerative colitis (UC) is a representative intestinal chronic inflammatory disease whose incidence is rapidly increasing worldwide. It was previously shown that some specific probiotics help to guard against UC. In this study, we analyzed the effect of Lactococcus lactis subsp. lactis JCM5805 (L. lactis), which has been put to practical use as a probiotic, on the pathogenesis of UC using a dextran sulfate sodium-induced colitis mouse model. Survival rate, length, and histopathological parameters of the colon were elucidated. Further, the concentrations of inflammatory cytokines in serum were measured. As a result, the oral administration of high-dose L. lactis showed significant decreases in survival rate and colon length. Histopathological analysis showed that a bleeding appearance was observed in the L. lactis group, and the histology scores in the L. lactis group were significantly higher than those in the normal saline group. Furthermore, the levels of interferon gamma, tumor necrosis factor alpha, and interleukin-6 were significantly elevated in the L. lactis group. These results support that high-dose administration of L. lactis deteriorates intestinal inflammation and suggest that the careful selection of probiotics strains and administration dose is important for improving colitis including UC. |
|---|---|
| AbstractList | Ulcerative colitis (UC) is a representative intestinal chronic inflammatory disease whose incidence is rapidly increasing worldwide. It was previously shown that some specific probiotics help to guard against UC. In this study, we analyzed the effect of Lactococcus lactis subsp. lactis JCM5805 (L. lactis), which has been put to practical use as a probiotic, on the pathogenesis of UC using a dextran sulfate sodium-induced colitis mouse model. Survival rate, length, and histopathological parameters of the colon were elucidated. Further, the concentrations of inflammatory cytokines in serum were measured. As a result, the oral administration of high-dose L. lactis showed significant decreases in survival rate and colon length. Histopathological analysis showed that a bleeding appearance was observed in the L. lactis group, and the histology scores in the L. lactis group were significantly higher than those in the normal saline group. Furthermore, the levels of interferon gamma, tumor necrosis factor alpha, and interleukin-6 were significantly elevated in the L. lactis group. These results support that high-dose administration of L. lactis deteriorates intestinal inflammation and suggest that the careful selection of probiotics strains and administration dose is important for improving colitis including UC. Ulcerative colitis (UC) is a representative intestinal chronic inflammatory disease whose incidence is rapidly increasing worldwide. It was previously shown that some specific probiotics help to guard against UC. In this study, we analyzed the effect of Lactococcus lactis subsp. lactis JCM5805 (L. lactis), which has been put to practical use as a probiotic, on the pathogenesis of UC using a dextran sulfate sodium-induced colitis mouse model. Survival rate, length, and histopathological parameters of the colon were elucidated. Further, the concentrations of inflammatory cytokines in serum were measured. As a result, the oral administration of high-dose L. lactis showed significant decreases in survival rate and colon length. Histopathological analysis showed that a bleeding appearance was observed in the L. lactis group, and the histology scores in the L. lactis group were significantly higher than those in the normal saline group. Furthermore, the levels of interferon gamma, tumor necrosis factor alpha, and interleukin-6 were significantly elevated in the L. lactis group. These results support that high-dose administration of L. lactis deteriorates intestinal inflammation and suggest that the careful selection of probiotics strains and administration dose is important for improving colitis including UC.Ulcerative colitis (UC) is a representative intestinal chronic inflammatory disease whose incidence is rapidly increasing worldwide. It was previously shown that some specific probiotics help to guard against UC. In this study, we analyzed the effect of Lactococcus lactis subsp. lactis JCM5805 (L. lactis), which has been put to practical use as a probiotic, on the pathogenesis of UC using a dextran sulfate sodium-induced colitis mouse model. Survival rate, length, and histopathological parameters of the colon were elucidated. Further, the concentrations of inflammatory cytokines in serum were measured. As a result, the oral administration of high-dose L. lactis showed significant decreases in survival rate and colon length. Histopathological analysis showed that a bleeding appearance was observed in the L. lactis group, and the histology scores in the L. lactis group were significantly higher than those in the normal saline group. Furthermore, the levels of interferon gamma, tumor necrosis factor alpha, and interleukin-6 were significantly elevated in the L. lactis group. These results support that high-dose administration of L. lactis deteriorates intestinal inflammation and suggest that the careful selection of probiotics strains and administration dose is important for improving colitis including UC. |
| Author | Komaki, Shinichirou Haque, Anwarul Nakamura, Shigeki Miyazaki, Haruko Matsumoto, Tetsuya |
| Author_xml | – sequence: 1 givenname: Shinichirou surname: Komaki fullname: Komaki, Shinichirou email: s-komaki@tokyo-med.ac.jp organization: Department of Microbiology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan – sequence: 2 givenname: Anwarul surname: Haque fullname: Haque, Anwarul organization: International University of Health and Welfare, School of Medicine, Kozunomori 4-3, Narita City, Chiba, 286-8686, Japan – sequence: 3 givenname: Haruko surname: Miyazaki fullname: Miyazaki, Haruko organization: Department of Microbiology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan – sequence: 4 givenname: Tetsuya surname: Matsumoto fullname: Matsumoto, Tetsuya organization: International University of Health and Welfare, School of Medicine, Kozunomori 4-3, Narita City, Chiba, 286-8686, Japan – sequence: 5 givenname: Shigeki surname: Nakamura fullname: Nakamura, Shigeki organization: Department of Microbiology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan |
| BackLink | https://cir.nii.ac.jp/crid/1872835442553004288$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/32122783$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkT2P1DAQhi10iPuAP0CBXFDQJPgjsR1Eg05wh7QSDSfRWY4zQV6y9hI76LbgvzPR3jZXHI09Y73PjGfeS3IWUwRCXnNWc8bV-229Dc7XgglWM14zpp6RC95IXWlt2BnGsuGVFPzHObnMecsY160xL8g5vgmhjbwgf-8i3O_BFxgojCMGNI10P6c-pBJ8pv2BbpwvySfvl0wnjEOmeenzvj5l7qcLMRfq0xTWPMRh8VgQ2QHuy-wiAtPoCtCchrDsUEF3wcNL8nx0U4ZXD_cVufvy-fv1bbX5dvP1-tOm8q1Qpeq8bseu6wenuG9904Dr3Ngq3XStkUIx3ePwRvVGDYIZDp3QTDHQo9BSuU5ekXfHujjY7wVysbuQPUyTi5CWbIXUDGtx1qL0zYN06Xcw2P0cdm4-2NPKUGCOAj-nnGcYrQ_FlZAiDhomy5ld3bFbu7pjV3cs4xY_iKh4hJ6qPwm9PUIxBGy1ntxoYWTbNKJtJWONMAZlH48ywD3-CTDb7ANEtCHM6KodUni6y4dHuJ-wl3fTLzj8D_4HSQjGXQ |
| CitedBy_id | crossref_primary_10_3390_jcm13051436 crossref_primary_10_1016_j_sjbs_2022_02_044 crossref_primary_10_1186_s12964_024_01611_z crossref_primary_10_1007_s00284_024_03997_y crossref_primary_10_1016_j_clim_2023_109683 crossref_primary_10_3748_wjg_v29_i14_2078 crossref_primary_10_1016_j_imlet_2022_11_002 crossref_primary_10_3390_ijms23179689 crossref_primary_10_1093_jambio_lxad008 crossref_primary_10_1016_j_lfs_2020_118129 crossref_primary_10_3389_fcimb_2023_1268041 crossref_primary_10_11648_j_bio_20241206_12 crossref_primary_10_1093_jpp_rgac078 crossref_primary_10_1021_acs_jafc_2c07098 |
| Cites_doi | 10.1016/j.apjtm.2017.08.017 10.1007/s11894-014-0396-y 10.1056/NEJMra020831 10.3748/wjg.v13.i42.5581 10.18632/oncotarget.16458 10.1002/mnfr.201100139 10.1002/ibd.20465 10.1186/1757-4749-6-33 10.1111/j.1365-2249.2010.04228.x 10.1053/j.gastro.2013.04.007 10.1016/S0168-1605(96)01233-0 10.1007/s12602-011-9087-2 10.1053/j.gastro.2016.10.020 10.3892/etm.2017.4402 10.1007/s00535-009-0057-3 10.1038/nrmicro2403 10.1128/AEM.01360-15 10.12938/bifidus1996.19.15 10.1099/jmm.0.000222 10.3748/wjg.v20.i1.6 10.1111/j.1751-7915.2011.00247.x 10.1371/journal.pone.0032588 10.1093/ajcn/69.5.1052s 10.1016/j.intimp.2009.08.018 10.1128/MMBR.00017-08 10.1053/j.gastro.2004.03.024 10.3748/wjg.v20.i42.15657 10.1016/j.intimp.2016.12.027 10.1038/ajg.2012.93 10.1371/journal.pone.0148241 |
| ContentType | Journal Article |
| Copyright | 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases Copyright © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases – notice: Copyright © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. |
| DBID | RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.jiac.2020.01.006 |
| DatabaseName | CiNii Complete CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1437-7780 |
| EndPage | 553 |
| ExternalDocumentID | 32122783 10_1016_j_jiac_2020_01_006 S1341321X20300209 |
| Genre | Journal Article |
| GroupedDBID | --- --M -Y2 -~C .1- .55 .86 .FO .~1 0R~ 0VY 1N0 1P~ 1SB 1~. 2.D 28- 29K 2JY 2P1 2VQ 2~H 30V 4.4 408 409 40D 457 4G. 53G 5GY 5QI 5VS 67Z 6NX 7-5 8P~ 8TC 8UJ 95. 95~ AAAJQ AAEDT AAEDW AAIAL AAIKJ AAKOC AALRI AANXM AAOAW AAQFI AARHV AATTM AAXKI AAXUO AAYWO AAYZH ABFSG ABJNI ABMAC ABMNI ABMZM ABQSL ABXDB ACDAQ ACGFS ACIEU ACOMO ACRLP ACSTC ACVFH ADBBV ADCNI ADEZE ADHKG ADIMF ADKPE ADQRH ADRFC ADVLN AEBSH AEFIE AEIPS AEKER AENEX AEUPX AEVXI AEZWR AFBBN AFEXP AFHIU AFLOW AFPUW AFRHN AFTJW AFWTZ AFXIZ AGCQF AGGDS AGHFR AGJBK AGQPQ AGUBO AHBYD AHKAY AHSBF AHWEU AIEXJ AIGII AIIUN AIKHN AITUG AIXLP AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMKLP AMRAJ ANKPU ANZVX ASPBG AVWKF AXJTR AZFZN BA0 BBWZM BGNMA BKOJK BLXMC BNPGV CAG CJTIS COF CS3 CSCUP D-I DL5 EBS EFJIC EFKBS EJD EMOBN EN4 F5P FDB FEDTE FIRID FYGXN GBLVA GQ8 GXS H13 HF~ HG5 HG6 HMJXF HVGLF HZ~ I09 IHE IXC IXE IZIGR IZQ I~X KDC KOM KOW KPH LAS M41 M4Y MA- MO0 N2Q N9A NB0 NDZJH NU0 O9- O93 O9G O9I OAM OAUVE OC~ P-8 P-9 P19 P2P P9S PC. PT5 QOK QOS R4E R89 R9I RNI ROL RPX RRX RSV RZK S1Z S26 S27 S28 S37 S3B SDE SDH SDM SMD SOJ SPCBC SSH SSZ SV3 T13 T16 T5K TSK TSV TT1 TUC U2A VC2 WJK WK8 X7M Z45 Z5R ~A9 ~EX ~G- -5E -5G -BR 0SF AACTN AAIAV ABLVK ABTEG ABYKQ ADINQ AFKWA AFNRJ AHPSJ AJBFU AJOXV AMFUW EFLBG GQ6 NCXOZ RIG SSI SZN Z7U Z82 Z87 Z8O Z8V Z91 AFCTW AGRNS RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c526t-9c75f99bda61c5c44ea9af567495832607b00686b86d2081e927060e7f2736a93 |
| IEDL.DBID | .~1 |
| ISSN | 1341-321X 1437-7780 |
| IngestDate | Mon Jul 21 12:00:30 EDT 2025 Wed Feb 19 02:28:43 EST 2025 Tue Jul 01 02:23:33 EDT 2025 Thu Apr 24 22:59:57 EDT 2025 Fri Jun 27 00:33:02 EDT 2025 Fri Feb 23 02:47:38 EST 2024 Tue Aug 26 16:59:28 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Lactococcus lactis Probiotics Dextran sulfate sodium-induced colitis |
| Language | English |
| License | Copyright © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c526t-9c75f99bda61c5c44ea9af567495832607b00686b86d2081e927060e7f2736a93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-8716-8401 |
| PMID | 32122783 |
| PQID | 2370495105 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_2370495105 pubmed_primary_32122783 crossref_citationtrail_10_1016_j_jiac_2020_01_006 crossref_primary_10_1016_j_jiac_2020_01_006 nii_cinii_1872835442553004288 elsevier_sciencedirect_doi_10_1016_j_jiac_2020_01_006 elsevier_clinicalkey_doi_10_1016_j_jiac_2020_01_006 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | June 2020 2020-06-01 2020-06-00 2020-Jun 20200601 |
| PublicationDateYYYYMMDD | 2020-06-01 |
| PublicationDate_xml | – month: 06 year: 2020 text: June 2020 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Journal of Infection and Chemotherapy |
| PublicationTitleAlternate | J Infect Chemother |
| PublicationYear | 2020 |
| Publisher | Elsevier Ltd Elsevier BV |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier BV |
| References | Claes, Lebeer, Shen, Verhoeven, Dilissen, De Hertogh (bib33) 2010; 162 Siezen, Bayjanov, Felis, van der Sijde, Starrenburg, Molenaar (bib14) 2011; 4 Cui, Wei, Lu, Liu, Liu, Gu (bib34) 2016; 11 Claes, De Keersmaecker, Vanderleyden, Lebeer (bib13) 2011; 55 Sartor (bib32) 2004; 126 Souza, Elian, Paula, Garcia, Vieira, Teixeira (bib1) 2016; 65 (bib12) 2002 Nishitani, Tanoue, Yamada, Ishida, Yoshida, Azuma (bib19) 2009; 9 Matts (bib21) 1961; 30 Stiles, Holzapfel (bib16) 1997; 36 Jounai, Ikado, Sugimura, Ano, Braun, Fujiwara (bib20) 2012; 7 Jadhav, Shandilya, Kansal (bib26) 2012; 4 Zhang, Wang, Tong, Sun, Liu, Zhang (bib28) 2017; 13 Khemariya, Singh, Nath, Gulati (bib15) 2017; 5 Luerce, Gomes-Santos, Rocha, Moreira, Cruz, Lemos (bib18) 2014; 6 Wallace, Zheng, Kanazawa, Shih (bib7) 2014; 20 Lebeer, Vanderleyden, De Keersmaecker (bib24) 2008; 72 Asakura, Nishiwaki, Inoue, Hibi, Watanabe, Takebayashi (bib5) 2009; 44 Keane, Dziki, Sobieski, Smoulder, Castleton, Turner (bib27) 2017; 11 O'Toole, Korzenik (bib6) 2014; 16 Lee, Yin, Griffey, Marco (bib11) 2015; 81 Damman, Miller, Surawicz, Zisman (bib9) 2012; 107 Oh, Ok, Jung, Jeon, Park, Jung (bib22) 2017; 10 Nell, Suerbaum, Josenhans (bib10) 2010; 8 Ng, Tang, Ching, Wong, Chow, Hui (bib3) 2013; 145 Kawada, Arihiro, Mizoguchi (bib29) 2007; 13 Chen, Ren, Shi (bib2) 2014; 20 Podolsky (bib23) 2002; 347 Isaacs, Herfarth (bib31) 2008; 14 Berlec, Perse, Ravnikar, Lunder, Erman, Cerar (bib17) 2017; 43 Mitsuoka (bib25) 2000; 19 Kaplan, Ng (bib8) 2017; 152 Yang, Chen, Yang, Ye, Cai, Tsering (bib4) 2017; 8 Collins, Gibson (bib30) 1999; 69 Yang (10.1016/j.jiac.2020.01.006_bib4) 2017; 8 O'Toole (10.1016/j.jiac.2020.01.006_bib6) 2014; 16 Siezen (10.1016/j.jiac.2020.01.006_bib14) 2011; 4 Sartor (10.1016/j.jiac.2020.01.006_bib32) 2004; 126 Damman (10.1016/j.jiac.2020.01.006_bib9) 2012; 107 Wallace (10.1016/j.jiac.2020.01.006_bib7) 2014; 20 Mitsuoka (10.1016/j.jiac.2020.01.006_bib25) 2000; 19 Kawada (10.1016/j.jiac.2020.01.006_bib29) 2007; 13 Collins (10.1016/j.jiac.2020.01.006_bib30) 1999; 69 Claes (10.1016/j.jiac.2020.01.006_bib13) 2011; 55 Lee (10.1016/j.jiac.2020.01.006_bib11) 2015; 81 Chen (10.1016/j.jiac.2020.01.006_bib2) 2014; 20 Podolsky (10.1016/j.jiac.2020.01.006_bib23) 2002; 347 Souza (10.1016/j.jiac.2020.01.006_bib1) 2016; 65 Ng (10.1016/j.jiac.2020.01.006_bib3) 2013; 145 Kaplan (10.1016/j.jiac.2020.01.006_bib8) 2017; 152 Nell (10.1016/j.jiac.2020.01.006_bib10) 2010; 8 Oh (10.1016/j.jiac.2020.01.006_bib22) 2017; 10 Jadhav (10.1016/j.jiac.2020.01.006_bib26) 2012; 4 Matts (10.1016/j.jiac.2020.01.006_bib21) 1961; 30 Luerce (10.1016/j.jiac.2020.01.006_bib18) 2014; 6 Asakura (10.1016/j.jiac.2020.01.006_bib5) 2009; 44 Berlec (10.1016/j.jiac.2020.01.006_bib17) 2017; 43 Lebeer (10.1016/j.jiac.2020.01.006_bib24) 2008; 72 Keane (10.1016/j.jiac.2020.01.006_bib27) 2017; 11 Stiles (10.1016/j.jiac.2020.01.006_bib16) 1997; 36 (10.1016/j.jiac.2020.01.006_bib12) 2002 Jounai (10.1016/j.jiac.2020.01.006_bib20) 2012; 7 Zhang (10.1016/j.jiac.2020.01.006_bib28) 2017; 13 Claes (10.1016/j.jiac.2020.01.006_bib33) 2010; 162 Cui (10.1016/j.jiac.2020.01.006_bib34) 2016; 11 Isaacs (10.1016/j.jiac.2020.01.006_bib31) 2008; 14 Nishitani (10.1016/j.jiac.2020.01.006_bib19) 2009; 9 Khemariya (10.1016/j.jiac.2020.01.006_bib15) 2017; 5 |
| References_xml | – volume: 6 start-page: 33 year: 2014 ident: bib18 article-title: Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis publication-title: Gut Pathog – volume: 19 start-page: 15 year: 2000 end-page: 25 ident: bib25 article-title: Significance of dietary modulation of intestinal flora and intestinal environment publication-title: Biosci Microflora – volume: 5 start-page: 556 year: 2017 end-page: 562 ident: bib15 article-title: Probiotic Lactococcus lactis: a review publication-title: Turk J Agric Food Sci Technol – volume: 126 start-page: 1620 year: 2004 end-page: 1633 ident: bib32 article-title: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics publication-title: Gastroenterology – volume: 11 start-page: 360 year: 2017 end-page: 368 ident: bib27 article-title: Restoring mucosal barrier function and modifying macrophage phenotype with an extracellular matrix hydrogel: potential therapy for ulcerative colitis publication-title: Journal of Crohn's & colitis – volume: 30 start-page: 393 year: 1961 end-page: 407 ident: bib21 article-title: The value of rectal biopsy in the diagnosis of ulcerative colitis publication-title: Q J Med – volume: 347 start-page: 417 year: 2002 end-page: 429 ident: bib23 article-title: Inflammatory bowel disease publication-title: N Engl J Med – volume: 69 start-page: 1052S year: 1999 end-page: 1057S ident: bib30 article-title: Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut publication-title: Am J Clin Nutr – volume: 11 start-page: e0148241 year: 2016 ident: bib34 article-title: Different effects of three selected Lactobacillus strains in dextran sulfate sodium-induced colitis in BALB/c mice publication-title: PloS One – volume: 4 start-page: 21 year: 2012 end-page: 26 ident: bib26 article-title: Immunoprotective effect of probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum on dextran sodium sulfate-induced ulcerative colitis in mice publication-title: Probiotics Antimicrob Protein – volume: 152 start-page: 313 year: 2017 end-page: 321 ident: bib8 article-title: Understanding and preventing the global increase of inflammatory bowel disease publication-title: Gastroenterology – volume: 145 start-page: 158 year: 2013 end-page: 165 ident: bib3 article-title: Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn's and colitis epidemiology study publication-title: Gastroenterology – volume: 55 start-page: 1441 year: 2011 end-page: 1453 ident: bib13 article-title: Lessons from probiotic-host interaction studies in murine models of experimental colitis publication-title: Mol Nutr Food Res – volume: 65 start-page: 201 year: 2016 end-page: 210 ident: bib1 article-title: Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model publication-title: J Med Microbiol – volume: 8 start-page: 48863 year: 2017 end-page: 48874 ident: bib4 article-title: Gut microbiota drives the attenuation of dextran sulphate sodium-induced colitis by Huangqin decoction publication-title: Oncotarget – volume: 16 start-page: 396 year: 2014 ident: bib6 article-title: Environmental triggers for IBD publication-title: Curr Gastroenterol Rep – volume: 43 start-page: 219 year: 2017 end-page: 226 ident: bib17 article-title: Dextran sulphate sodium colitis in C57BL/6J mice is alleviated by Lactococcus lactis and worsened by the neutralization of Tumor necrosis Factor alpha publication-title: Int Immunopharm – volume: 20 start-page: 6 year: 2014 end-page: 21 ident: bib7 article-title: Immunopathology of inflammatory bowel disease publication-title: World J Gastroenterol – volume: 8 start-page: 564 year: 2010 end-page: 577 ident: bib10 article-title: The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models publication-title: Nat Rev Microbiol – volume: 14 start-page: 1597 year: 2008 end-page: 1605 ident: bib31 article-title: Role of probiotic therapy in IBD publication-title: Inflamm Bowel Dis – volume: 20 start-page: 15657 year: 2014 end-page: 15663 ident: bib2 article-title: Enteric microbiota leads to new therapeutic strategies for ulcerative colitis publication-title: World J Gastroenterol – year: 2002 ident: bib12 article-title: Guidelines for the evaluation of probiotics in food – volume: 72 start-page: 728 year: 2008 end-page: 764 ident: bib24 article-title: Genes and molecules of lactobacilli supporting probiotic action publication-title: Microbiol Mol Biol Rev – volume: 9 start-page: 1444 year: 2009 end-page: 1451 ident: bib19 article-title: Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice publication-title: Int Immunopharm – volume: 44 start-page: 659 year: 2009 end-page: 665 ident: bib5 article-title: Prevalence of ulcerative colitis and Crohn's disease in Japan publication-title: J Gastroenterol – volume: 162 start-page: 306 year: 2010 end-page: 314 ident: bib33 article-title: Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis publication-title: Clin Exp Immunol – volume: 13 start-page: 3374 year: 2017 end-page: 3382 ident: bib28 article-title: Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress publication-title: Exp Therapeut Med – volume: 13 start-page: 5581 year: 2007 end-page: 5593 ident: bib29 article-title: Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease publication-title: World J Gastroenterol – volume: 107 start-page: 1452 year: 2012 end-page: 1459 ident: bib9 article-title: The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? publication-title: Am J Gastroenterol – volume: 10 start-page: 864 year: 2017 end-page: 870 ident: bib22 article-title: Protective effect of decursin and decursinol angelate-rich Angelica gigas Nakai extract on dextran sulfate sodium-induced murine ulcerative colitis publication-title: Asian Pac J Trop Med – volume: 81 start-page: 6425 year: 2015 end-page: 6435 ident: bib11 article-title: Attenuation of colitis by Lactobacillus casei BL23 is dependent on the dairy delivery matrix publication-title: Appl Environ Microbiol – volume: 7 start-page: e32588 year: 2012 ident: bib20 article-title: Spherical lactic acid bacteria active plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells publication-title: PLoS One – volume: 4 start-page: 383 year: 2011 end-page: 402 ident: bib14 article-title: Genome-scale diversity and niche adaptation analysis of Lactococcus lactis by comparative genome hybridization using multi-strain arrays publication-title: Microb Biotechnol – volume: 36 start-page: 1 year: 1997 end-page: 29 ident: bib16 article-title: Lactic acid bacteria of foods and their current taxonomy publication-title: Int J Food Microbiol – volume: 10 start-page: 864 year: 2017 ident: 10.1016/j.jiac.2020.01.006_bib22 article-title: Protective effect of decursin and decursinol angelate-rich Angelica gigas Nakai extract on dextran sulfate sodium-induced murine ulcerative colitis publication-title: Asian Pac J Trop Med doi: 10.1016/j.apjtm.2017.08.017 – volume: 16 start-page: 396 year: 2014 ident: 10.1016/j.jiac.2020.01.006_bib6 article-title: Environmental triggers for IBD publication-title: Curr Gastroenterol Rep doi: 10.1007/s11894-014-0396-y – volume: 5 start-page: 556 year: 2017 ident: 10.1016/j.jiac.2020.01.006_bib15 article-title: Probiotic Lactococcus lactis: a review publication-title: Turk J Agric Food Sci Technol – volume: 30 start-page: 393 year: 1961 ident: 10.1016/j.jiac.2020.01.006_bib21 article-title: The value of rectal biopsy in the diagnosis of ulcerative colitis publication-title: Q J Med – volume: 347 start-page: 417 year: 2002 ident: 10.1016/j.jiac.2020.01.006_bib23 article-title: Inflammatory bowel disease publication-title: N Engl J Med doi: 10.1056/NEJMra020831 – volume: 11 start-page: 360 year: 2017 ident: 10.1016/j.jiac.2020.01.006_bib27 article-title: Restoring mucosal barrier function and modifying macrophage phenotype with an extracellular matrix hydrogel: potential therapy for ulcerative colitis publication-title: Journal of Crohn's & colitis – volume: 13 start-page: 5581 year: 2007 ident: 10.1016/j.jiac.2020.01.006_bib29 article-title: Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease publication-title: World J Gastroenterol doi: 10.3748/wjg.v13.i42.5581 – volume: 8 start-page: 48863 year: 2017 ident: 10.1016/j.jiac.2020.01.006_bib4 article-title: Gut microbiota drives the attenuation of dextran sulphate sodium-induced colitis by Huangqin decoction publication-title: Oncotarget doi: 10.18632/oncotarget.16458 – volume: 55 start-page: 1441 year: 2011 ident: 10.1016/j.jiac.2020.01.006_bib13 article-title: Lessons from probiotic-host interaction studies in murine models of experimental colitis publication-title: Mol Nutr Food Res doi: 10.1002/mnfr.201100139 – volume: 14 start-page: 1597 year: 2008 ident: 10.1016/j.jiac.2020.01.006_bib31 article-title: Role of probiotic therapy in IBD publication-title: Inflamm Bowel Dis doi: 10.1002/ibd.20465 – volume: 6 start-page: 33 year: 2014 ident: 10.1016/j.jiac.2020.01.006_bib18 article-title: Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis publication-title: Gut Pathog doi: 10.1186/1757-4749-6-33 – volume: 162 start-page: 306 year: 2010 ident: 10.1016/j.jiac.2020.01.006_bib33 article-title: Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2010.04228.x – volume: 145 start-page: 158 year: 2013 ident: 10.1016/j.jiac.2020.01.006_bib3 article-title: Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn's and colitis epidemiology study publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.04.007 – volume: 36 start-page: 1 year: 1997 ident: 10.1016/j.jiac.2020.01.006_bib16 article-title: Lactic acid bacteria of foods and their current taxonomy publication-title: Int J Food Microbiol doi: 10.1016/S0168-1605(96)01233-0 – volume: 4 start-page: 21 year: 2012 ident: 10.1016/j.jiac.2020.01.006_bib26 article-title: Immunoprotective effect of probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum on dextran sodium sulfate-induced ulcerative colitis in mice publication-title: Probiotics Antimicrob Protein doi: 10.1007/s12602-011-9087-2 – volume: 152 start-page: 313 year: 2017 ident: 10.1016/j.jiac.2020.01.006_bib8 article-title: Understanding and preventing the global increase of inflammatory bowel disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.10.020 – volume: 13 start-page: 3374 year: 2017 ident: 10.1016/j.jiac.2020.01.006_bib28 article-title: Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress publication-title: Exp Therapeut Med doi: 10.3892/etm.2017.4402 – volume: 44 start-page: 659 year: 2009 ident: 10.1016/j.jiac.2020.01.006_bib5 article-title: Prevalence of ulcerative colitis and Crohn's disease in Japan publication-title: J Gastroenterol doi: 10.1007/s00535-009-0057-3 – volume: 8 start-page: 564 year: 2010 ident: 10.1016/j.jiac.2020.01.006_bib10 article-title: The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro2403 – volume: 81 start-page: 6425 year: 2015 ident: 10.1016/j.jiac.2020.01.006_bib11 article-title: Attenuation of colitis by Lactobacillus casei BL23 is dependent on the dairy delivery matrix publication-title: Appl Environ Microbiol doi: 10.1128/AEM.01360-15 – volume: 19 start-page: 15 year: 2000 ident: 10.1016/j.jiac.2020.01.006_bib25 article-title: Significance of dietary modulation of intestinal flora and intestinal environment publication-title: Biosci Microflora doi: 10.12938/bifidus1996.19.15 – volume: 65 start-page: 201 year: 2016 ident: 10.1016/j.jiac.2020.01.006_bib1 article-title: Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model publication-title: J Med Microbiol doi: 10.1099/jmm.0.000222 – volume: 20 start-page: 6 year: 2014 ident: 10.1016/j.jiac.2020.01.006_bib7 article-title: Immunopathology of inflammatory bowel disease publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i1.6 – volume: 4 start-page: 383 year: 2011 ident: 10.1016/j.jiac.2020.01.006_bib14 article-title: Genome-scale diversity and niche adaptation analysis of Lactococcus lactis by comparative genome hybridization using multi-strain arrays publication-title: Microb Biotechnol doi: 10.1111/j.1751-7915.2011.00247.x – volume: 7 start-page: e32588 year: 2012 ident: 10.1016/j.jiac.2020.01.006_bib20 article-title: Spherical lactic acid bacteria active plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells publication-title: PLoS One doi: 10.1371/journal.pone.0032588 – volume: 69 start-page: 1052S year: 1999 ident: 10.1016/j.jiac.2020.01.006_bib30 article-title: Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut publication-title: Am J Clin Nutr doi: 10.1093/ajcn/69.5.1052s – volume: 9 start-page: 1444 year: 2009 ident: 10.1016/j.jiac.2020.01.006_bib19 article-title: Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice publication-title: Int Immunopharm doi: 10.1016/j.intimp.2009.08.018 – volume: 72 start-page: 728 year: 2008 ident: 10.1016/j.jiac.2020.01.006_bib24 article-title: Genes and molecules of lactobacilli supporting probiotic action publication-title: Microbiol Mol Biol Rev doi: 10.1128/MMBR.00017-08 – year: 2002 ident: 10.1016/j.jiac.2020.01.006_bib12 – volume: 126 start-page: 1620 year: 2004 ident: 10.1016/j.jiac.2020.01.006_bib32 article-title: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.03.024 – volume: 20 start-page: 15657 year: 2014 ident: 10.1016/j.jiac.2020.01.006_bib2 article-title: Enteric microbiota leads to new therapeutic strategies for ulcerative colitis publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i42.15657 – volume: 43 start-page: 219 year: 2017 ident: 10.1016/j.jiac.2020.01.006_bib17 article-title: Dextran sulphate sodium colitis in C57BL/6J mice is alleviated by Lactococcus lactis and worsened by the neutralization of Tumor necrosis Factor alpha publication-title: Int Immunopharm doi: 10.1016/j.intimp.2016.12.027 – volume: 107 start-page: 1452 year: 2012 ident: 10.1016/j.jiac.2020.01.006_bib9 article-title: The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? publication-title: Am J Gastroenterol doi: 10.1038/ajg.2012.93 – volume: 11 start-page: e0148241 year: 2016 ident: 10.1016/j.jiac.2020.01.006_bib34 article-title: Different effects of three selected Lactobacillus strains in dextran sulfate sodium-induced colitis in BALB/c mice publication-title: PloS One doi: 10.1371/journal.pone.0148241 |
| SSID | ssj0017588 ssib050995435 ssib002821768 ssib058493233 |
| Score | 2.309108 |
| Snippet | Ulcerative colitis (UC) is a representative intestinal chronic inflammatory disease whose incidence is rapidly increasing worldwide. It was previously shown... |
| SourceID | proquest pubmed crossref nii elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 549 |
| SubjectTerms | Animals Colitis, Ulcerative Colitis, Ulcerative - chemically induced Colitis, Ulcerative - microbiology Colitis, Ulcerative - pathology Colon Colon - immunology Colon - pathology Cytokines Cytokines - blood Dextran Sulfate Dextran sulfate sodium-induced colitis Disease Models, Animal Female Lactococcus lactis Mice Mice, Inbred C57BL Probiotics Probiotics - administration & dosage Probiotics - adverse effects Survival Analysis |
| Title | Unexpected effect of probiotics by Lactococcus lactis subsp. lactis against colitis induced by dextran sulfate sodium in mice |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1341321X20300209 https://dx.doi.org/10.1016/j.jiac.2020.01.006 https://cir.nii.ac.jp/crid/1872835442553004288 https://www.ncbi.nlm.nih.gov/pubmed/32122783 https://www.proquest.com/docview/2370495105 |
| Volume | 26 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZpeumlpO_NCxVKLomztl62jyE0bF8hkCzsTUiWHBw23iXePewh-e2Zke0NhTaFXgw2GmxZ428-4ZlvCPkSK5fnlstIKW8jYZmIrLEsUrHPM5YyaznWO_86V6Ox-D6Rkw1y2tfCYFplh_0tpge07q4Mu7c5nFfV8BKlyDhLJgz8FEgPFvEJkaKXHz-s0zwgOobekzg4wtFd4Uyb43VTGZQxZHGQ7sSuR38OTi_qqvo7BQ2h6GyLvO44JD1pH_MN2fD1W3Jw0YpQr47o1VNNVXNED-jFkzz16h25H9co618A1aRtNgedlXQe9JjQgtoV_YldeAAqi2VDp1j60NAGEGZ-3J-Za1MBsaRFSJ9rKOzswUcc2jqAewiAYDAtgcjSZuaq5S2MoLcASu_J-Ozr1eko6powRIVkahHlRSpLWE5nVFLIQghvclNKlcLOCtBAxakNZSY2U44Bv_A5Q0Een5ZAjJTJ-QeyWc9q_4lQUxqTGVFmlnMhXQyOkfjSJcoB6ibODkjSv31ddArl2ChjqvtUtBuNK6ZxxXScaLjxgByubeatPsezo3m_qLqvPAWs1BA-nrWSa6vffPOfdnvgNzAVPCZZitJ2AjBS8rBTzQbkc-9RGj5q_FNjaj9bNprxFHZuyH0H5GPrauvZgRNj-TLf_s-n2iGv8KxNd9slm4u7pd8DYrWw--HL2ScvT779GJ0_AofBH1w |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1da9swFL206cP2Mva9bOumwejL6sWWLNl-LGUlXdNQWAJ9E5IlD5fUCXPykIf9993rj5TB1sFeDLZ18Yeuj47wPUcAH0PlsswKGSjlbRBbHgfWWB6o0GcpT7i1gvTOl1M1nsdfr-X1Hpz2Whgqq-ywv8X0Bq27I6PubY5WZTn6RlZkgkfXHPMUSU-2DwfkTiUHcHByfjGe7n4mICVuFHHYPqCATjvTlnndlIacDHnYuHfSwkd_Hp_2q7L8OwttRqOzx_Coo5HspL3TJ7Dnq6dwdNX6UG-P2exOVlUfsyN2dedQvX0GP-cVOfvnyDZZW9DBlgVbNZZMFMHslk1oIR5Ey3xTswWpH2pWI8isPvd75rspkVuyvKmgqxlO7jFNHMU6RHwcAzFgUSCXZfXSlZtbbMFuEZeew_zsy-x0HHTrMAS55GodZHkiC-xRZ1SUyzyOvclMIVWCkysEBBUmtlGa2FQ5jhTDZ5w8eXxSIDdSJhMvYFAtK_8KmCmMSU1cpFaIWLoQcyPyhYuUQ-CNnB1C1L99nXcm5bRWxkL31Wg3mnpMU4_pMNJ44SF82sWsWouOe1uLvlN1Lz5FuNQ4gtwbJXdRv6XnP-MOMW_wUWgbpQm528UIk1I0k9V0CB_6jNL4XdPPGlP55abWXCQ4eSP6O4SXbartng6TmBTM4vV_3tV7eDCeXU705Hx68QYe0pm2-u0tDNY_Nv4Qedbavuu-o19UJSIN |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Unexpected+effect+of+probiotics+by+Lactococcus+lactis+subsp.+lactis+against+colitis+induced+by+dextran+sulfate+sodium+in+mice&rft.jtitle=Journal+of+infection+and+chemotherapy+%3A+official+journal+of+the+Japan+Society+of+Chemotherapy&rft.au=Komaki%2C+Shinichirou&rft.au=Haque%2C+Anwarul&rft.au=Miyazaki%2C+Haruko&rft.au=Matsumoto%2C+Tetsuya&rft.date=2020-06-01&rft.pub=Elsevier+Ltd&rft.issn=1341-321X&rft.eissn=1437-7780&rft.volume=26&rft.issue=6&rft.spage=549&rft.epage=553&rft_id=info:doi/10.1016%2Fj.jiac.2020.01.006&rft.externalDocID=S1341321X20300209 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-321X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-321X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-321X&client=summon |